Speciality Medicines IPO Subscription Status
The Speciality Medicines IPO has been subscribed 2.19x times overall. Retail investors have shown interest with bids for 0.85x the shares available. The Non-Institutional Investor (NII) category has been subscribed 1.77x. Qualified Institutional Buyers (QIBs) have subscribed 96.24x. Data last updated on 09 Apr, 05:09 PM.
The IPO subscription period has ended. The issue opened on 20 Mar, 2026 and closes on 24 Mar, 2026. The shares are expected to list on stock exchanges on 30 Mar, 2026.
Table of Contents
Live Bidding
| Category | Offered | Applied | Bid Details | TIMES |
|---|---|---|---|---|
|
QIB
|
21,000 | 20,21,000 |
20,21,000
of 21,000
|
96.24x |
|
NII
|
12,39,000 | 21,94,000 |
21,94,000
of 12,39,000
|
1.77x |
|
Retail
|
10,90,000 | 9,22,000 |
9,22,000
of 10,90,000
|
0.85x |
| TOTAL | 23,50,000 | 51,37,000 |
51,37,000
-
|
2.19x |
Last Updated: 09 Apr 2026, 05:09 PM
Retail Allotment
Currently undersubscribed. Retail investors applying now have a high mathematical probability of receiving full allotment.
Institutional Backing
Massive institutional interest with QIBs subscribing 96.24x. This often signals long-term confidence from professional funds.
Day-wise Subscription History
Subscription trends over the last 3 days
| Date | Total | ||
|---|---|---|---|
|
24 Mar 2026
DAY 3
|
2.19x
|
||
|
QIB
96.24x
NII
1.77x
Retail
0.85x
|
|||
|
23 Mar 2026
DAY 2
|
0.94x
|
||
|
QIB
1x
NII
1.6x
Retail
0.19x
|
|||
|
20 Mar 2026
DAY 1
|
0.78x
|
||
|
QIB
1x
NII
1.41x
Retail
0.07x
|
|||
IPO Guru on Android
Get live GMP alerts, subscription updates, and allotment status directly on your phone. Fast, Free, and Secure.
Speciality Medicines IPO Allotment Probability
Allotment probability is calculated based on current subscription multiples. Retail allotment is by lottery when oversubscribed; NII allotment is proportionate. Final numbers may change until subscription closes. This is not investment advice.
What Does This Subscription Data Mean?
IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:
- QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
- NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
- Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
- Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.
Data sourced from BSE/NSE. Subscription numbers are updated during market hours (10 AM – 5 PM IST) on active subscription days.
Frequently Asked Questions
What is the current subscription status of Speciality Medicines IPO?
As of IPO close date (24 Mar, 2026), the Speciality Medicines IPO is subscribed 2.19x times. Retail category is 0.85x, and NII is 1.77x subscribed.
When is the allotment date for Speciality Medicines IPO?
The allotment for Speciality Medicines IPO is expected to be finalized on 25 March, 2026.
When will Speciality Medicines IPO list on the stock market?
Speciality Medicines is scheduled to list on BSE and NSE on 30 March, 2026.
What are the chances of getting allotment in Speciality Medicines IPO?
The retail category is currently undersubscribed at 0.85x, which means most applicants are likely to receive full allotment. This is a good window to apply if you haven't already.
What does QIB subscription of 96.24x mean for Speciality Medicines IPO?
Strong — QIBs (mutual funds, FIIs, insurance companies) have subscribed 96.24x, indicating high institutional conviction. Heavy QIB demand is historically one of the strongest predictors of a positive listing.
How to check Speciality Medicines IPO allotment status?
After the allotment date (25 Mar, 2026), you can check your Speciality Medicines IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.
Explore Speciality Medicines IPO Further
Track every stage of this IPO from subscription to listing:
Discussion 0
No comments yet
Be the first to share your thoughts!